What is NDC 51662-1596?

51662-1596 is the product NDC for LIDOCAINE HCl, Lidocaine hydrochloride 40 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for LIDOCAINE HCl?

6 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

LIDOCAINE HCl NDC 51662-1596 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1596Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1596Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1596-3	51662159603	25 POUCH in 1 CASE (51662-1596-3) / 1 AMPULE in 1 POUCH (51662-1596-2) / 5 mL in 1 AMPULEMarketed from Sep 15, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): LIDOCAINE HCl
Generic name (nonproprietary): lidocaine hcl
Active ingredients: Lidocaine hydrochloride — 40 mg/mL
Dosage form: Injection, Solution
Route: Retrobulbar, Topical, Transtracheal
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 088295
Marketing start: Sep 15, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1596_0ff8ef97-0071-e6ca-e063-6294a90a2365SPL ID 0ff8ef97-0071-e6ca-e063-6294a90a2365SPL set ID e8bc96bc-7876-4906-e053-2a95a90ae6baRxCUI 1010844UNII V13007Z41A
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451662159603 followed by a unit qualifier and the quantity

Package 51662-1596-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 27, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE 4% Lidocaine Hydrochloride Injection, USP is indicated for the production of topical anesthesia of the mucous membranes of the respiratory tract or the genito-urinary tract. It may be injected trans-tracheally to anesthetize the larynx and trachea, and it may be administered by retrobulbar injection to provide anesthesia for ophthalmic surgery.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1596

What is NDC 51662-1596?: 51662-1596 is the product NDC for LIDOCAINE HCl, Lidocaine hydrochloride 40 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: LIDOCAINE HCl.
What is the active ingredient?: Lidocaine hydrochloride.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for LIDOCAINE HCl?: 6 other product NDCs are listed under this name. See all LIDOCAINE HCl NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other LIDOCAINE HCl NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lidocaine HCl	Lidocaine hydrochloride anhydrous 5 mg/g	GelTopical	Topco Associates LLC	76162-034	76162-0034-34
Lidocaine HCL	Lidocaine hydrochloride 4 g/100g	CreamTopical	Matthias Therapeutics, LLC	87137-101	87137-0101-07
LIDOCAINE HCl	Lidocaine hydrochloride 10 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1593	51662-1593-03
LIDOCAINE HCl	Lidocaine hydrochloride 40 mg/mL	SolutionTopical	HF Acquisition Co LLC, DBA HealthFirst	51662-1553	51662-1553-03
LIDOCAINE HCl	Lidocaine hydrochloride 10 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	HF Acquisition Co LLC, DBA HealthFirst	51662-1538	51662-1538-0151662-1538-03
LIDOCAINE HCl	Lidocaine hydrochloride 10 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal	HF Acquisition Co LLC, DBA HealthFirst	51662-1438	51662-1438-0151662-1438-03

Other NDCs under ANDA 088295

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 088295
Product	Strength	Form · route	Labeler	Product NDC
Lidocaine Hydrochloride	Lidocaine hydrochloride 40 mg/mL	Injection, SolutionRetrobulbar, Topical	Hospira, Inc.	0409-4283